{"id":55900,"date":"2023-02-01T11:00:28","date_gmt":"2023-02-01T16:00:28","guid":{"rendered":"https:\/\/wfh.org\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/"},"modified":"2024-04-09T09:07:58","modified_gmt":"2024-04-09T13:07:58","slug":"la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses","status":"publish","type":"post","link":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/","title":{"rendered":"La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"55900\" class=\"elementor elementor-55900 elementor-54686\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-186e901 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"186e901\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3dcc505\" data-id=\"3dcc505\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-132e5c6 elementor-widget elementor-widget-text-editor\" data-id=\"132e5c6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Cette proposition s\u2019aligne sur les politiques en place dans des pays comme le Royaume-Uni et le Canada. Les recommandations r\u00e9dig\u00e9es par la FDA se fondent sur l\u2019examen attentif par l\u2019agence des informations disponibles, notamment de donn\u00e9es provenant d\u2019autres pays pr\u00e9sentant une \u00e9pid\u00e9miologie similaire du VIH et qui ont adopt\u00e9 cette approche, ainsi que sur la surveillance active des stocks de sang des \u00c9tats-Unis.<\/p>\n<p>Pour lire le communiqu\u00e9 de presse int\u00e9gral de la FDA (en anglais), <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-proposes-individual-risk-assessment-blood-donations-while-continuing-safeguard-us-blood-supply?utm_medium=email&amp;utm_source=govdelivery\" target=\"_blank\" rel=\"noopener\">cliquez ici<\/a>.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>La Food and Drug Administration (FDA) des \u00c9tats-Unis a annonc\u00e9 sa proposition d\u2019abandonner les exclusions bas\u00e9es sur les d\u00e9lais pour \u00e9valuer l\u2019\u00e9ligibilit\u00e9 des donneurs de donneuses de sang, au profit de questions individuelles et inclusives en mati\u00e8re de genre, pour r\u00e9duire le risque de transmission du VIH par transfusion. <\/p>\n","protected":false},"author":13,"featured_media":30514,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[197],"tags":[],"search-category":[85],"class_list":["post-55900","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-declarations-publiques-et-recommandations-de-la-fmh","search-category-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis\" \/>\n<meta property=\"og:description\" content=\"La Food and Drug Administration (FDA) des \u00c9tats-Unis a annonc\u00e9 sa proposition d\u2019abandonner les exclusions bas\u00e9es sur les d\u00e9lais pour \u00e9valuer l\u2019\u00e9ligibilit\u00e9 des donneurs de donneuses de sang, au profit de questions individuelles et inclusives en mati\u00e8re de genre, pour r\u00e9duire le risque de transmission du VIH par transfusion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-01T16:00:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-09T13:07:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2501\" \/>\n\t<meta property=\"og:image:height\" content=\"1459\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mitch Semienchuk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mitch Semienchuk\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/\"},\"author\":{\"name\":\"Mitch Semienchuk\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b\"},\"headline\":\"La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis\",\"datePublished\":\"2023-02-01T16:00:28+00:00\",\"dateModified\":\"2024-04-09T13:07:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/\"},\"wordCount\":120,\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\",\"articleSection\":[\"D\u00e9clarations publiques et recommandations de la FMH\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/\",\"url\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/\",\"name\":\"La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\",\"datePublished\":\"2023-02-01T16:00:28+00:00\",\"dateModified\":\"2024-04-09T13:07:58+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#primaryimage\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png\",\"width\":2501,\"height\":1459,\"caption\":\"lgoo\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wfh.org\/fr\/#website\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"name\":\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"description\":\"WFH - World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wfh.org\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wfh.org\/fr\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/wfhemophilia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b\",\"name\":\"Mitch Semienchuk\",\"sameAs\":[\"analytics\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/","og_locale":"fr_FR","og_type":"article","og_title":"La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis","og_description":"La Food and Drug Administration (FDA) des \u00c9tats-Unis a annonc\u00e9 sa proposition d\u2019abandonner les exclusions bas\u00e9es sur les d\u00e9lais pour \u00e9valuer l\u2019\u00e9ligibilit\u00e9 des donneurs de donneuses de sang, au profit de questions individuelles et inclusives en mati\u00e8re de genre, pour r\u00e9duire le risque de transmission du VIH par transfusion.","og_url":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/","og_site_name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_published_time":"2023-02-01T16:00:28+00:00","article_modified_time":"2024-04-09T13:07:58+00:00","og_image":[{"width":2501,"height":1459,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","type":"image\/png"}],"author":"Mitch Semienchuk","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Mitch Semienchuk"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#article","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/"},"author":{"name":"Mitch Semienchuk","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b"},"headline":"La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis","datePublished":"2023-02-01T16:00:28+00:00","dateModified":"2024-04-09T13:07:58+00:00","mainEntityOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/"},"wordCount":120,"publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","articleSection":["D\u00e9clarations publiques et recommandations de la FMH"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/","url":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/","name":"La FDA propose une \u00e9valuation individuelle des risques pour les dons de sang, dans le cadre d\u2019une r\u00e9vision des politiques d\u2019\u00e9ligibilit\u00e9 et d\u2019exclusion des donneurs et donneuses aux \u00c9tats-Unis | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","datePublished":"2023-02-01T16:00:28+00:00","dateModified":"2024-04-09T13:07:58+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/article\/la-fda-propose-une-evaluation-individuelle-des-risques-pour-les-dons-de-sang-dans-le-cadre-dune-revision-des-politiques-deligibilite-et-dexclusion-des-donneurs-et-donneuses\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/03\/WFH-statement-News-FR.png","width":2501,"height":1459,"caption":"lgoo"},{"@type":"WebSite","@id":"https:\/\/wfh.org\/fr\/#website","url":"https:\/\/wfh.org\/fr\/","name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","description":"WFH - World Federation of Hemophilia","publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/wfh.org\/fr\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"]},{"@type":"Person","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b","name":"Mitch Semienchuk","sameAs":["analytics"]}]}},"_links":{"self":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/55900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/comments?post=55900"}],"version-history":[{"count":0,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/55900\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media\/30514"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media?parent=55900"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/categories?post=55900"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/tags?post=55900"},{"taxonomy":"search-category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/search-category?post=55900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}